All In MedTech

Device Trial Radar · NCT04737447

Whole Body Vibration Training in the Treatment for Children's Incontinence - a Randomized-Controlled Trial

Last checked: Nov 19, 2026Latest source record: Dec 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Jan 15, 2019

Primary completion

Jan 31, 2023

Study completion Jan 31, 2023

Sponsor

Lead sponsor
University Children's Hospital, ZurichAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 3, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 7 years, up to 16 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The determined study category is a prospective clinical randomized controlled study to evaluate the effect of WBVT in combination with urophysiotherapy to playfully expand the therapeutic options for children and adolescents with incontinence. This will be the first time use of WBVT for treating incontinence in children.

Conditions

  • Incontinence, Urinary

Interventions

  • Whole Body Vibration TrainingDevice

    Galileo® Trainer is a vibration board. The movement alternating to different sides during walking correlates with the movement on the board due to variable amplitudes and frequencies. Movements of the vibration board are quickly changing and thus simulating the tilting movements of the pelvic during walking but with higher frequency. Muscles of legs and core are activated reflexively. In our study there are performed static practices and pelvic activating practices. Each physiotherapist is experienced in the technical and practical handling of the device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of Dysfunctional Voiding and Incontinence Score (DVISS)Time frame: Change of DVISS between Baseline and Post-interventional at 12 weeks after Beginning of Intervention, 24 and 48 weeks after Intervention
  2. Change of Revised Urinary Incontinence Scale (RUIS)Time frame: Change of RUIS between Baseline and post-interventional (12 weeks after Beginning of Intervention, 24 and 48 weeks after Intervention)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Children's Hospital

    Zurich, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.